Tech Company Financing Transactions
Bright Biotech Funding Round
Bright Biotech closed a $3.2 million funding round on 11/22/2022. Backers included FoodLabs, Big Idea Ventures and CPT Capital.
Transaction Overview
Company Name
Announced On
11/22/2022
Transaction Type
Venture Equity
Amount
$3,200,000
Round
Undisclosed
Investors
Proceeds Purpose
The aim is to reach the market with an early iteration of Bright Biotech's product sometime next year. One of the biggest potential cost savings stems from the price of plant-based growth factors used to expand animal cells, enabling them to expand and transform into animal flesh.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Greenheys Unit 51, Manchester Science Park Pencroft Way
Manchester, M15 6SE
UK
Manchester, M15 6SE
UK
Phone
Website
Email Address
Overview
A proprietary light-driven, protein expression technology that uses chloroplasts to make extraordinarily high yields of proteins in plants. This game-changing manufacturing system is sustainable, free of animal pathogens and bacterial endotoxins, and highly scalable.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Mohammad Hajj
Chief Operating Officer
Tariq Ali
Chief Technical Officer
Rania Deranieh
Co-Founder
Anil Day
Co-Founder
Farid Khan
Browse more venture capital transactions:
Prev: 11/22/2022: Leta venture capital transaction
Next: 11/22/2022: WorkJam venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC transactions reported here are derived from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs